Table 1.
Clinical and hemodynamic characteristics of the participants
| Parameter | Total (n = 100) | Men (n = 48) | Women (n = 52) | p (men vs. women) |
|---|---|---|---|---|
| Age, yrs | 67.5 (54.0–75.0) | 65.0 (50.3–74.8) | 70.0 (59.5–76.0) | 0.169 |
| BMI, kg/m2 | 24.1±3.4 | 24.9±3.5 | 23.5±3.1 | 0.035 |
| BSA, m2 | 1.62±0.19 | 1.77±0.17 | 1.49±0.10 | <0.001 |
| ACEI/ARB use, n (%) | 37 (37) | 19 (39) | 18 (34) | 0.876 |
| CCB use, n (%) | 22 (22) | 9 (18) | 13 (25) | 0.753 |
| β-blocker use, n (%) | 5 (5) | 2 (4) | 3 (5) | 0.935 |
|
| ||||
| Hemodynamic and echocardiographic parameters | ||||
| Heart rate, beats/min | 70.7±10.9 | 72.1±9.9 | 69.3±11.7 | 0.204 |
| Brachial SBP, mm Hg | 146.5±14.0 | 144.7±15.2 | 148.1±12.7 | 0.225 |
| Brachial DBP, mm Hg | 91.5±10.3 | 92.6±10.1 | 90.4±10.5 | 0.288 |
| Central SBP, mm Hg | 135.0±14.0 | 133.2±14.1 | 136.5±13.9 | 0.240 |
| Central AP, mm Hg | 14.4±7.8 | 11.2±6.2 | 17.3±8.1 | <0.001 |
| Central AIx, % | 32.7±13.4 | 27.3±10.9 | 37.6±13.7 | <0.001 |
| RWT | 0.498±0.051 | 0.496±0.052 | 0.499±0.051 | 0.812 |
| LVM, g | 182.2±30.5 | 202.6±24.3 | 163.3±22.6 | <0.001 |
| LVMI, g/m2 | 112.6±16.0 | 115.5±15.8 | 109.8±16.0 | 0.076 |
| Aortic root diameter, mm | 33.1±4.0 | 34.9±2.0 | 31.4±3.0 | <0.001 |
Data are presented as means±standard deviations if normally distributed and as medians (IQRs) if not. BMI, body mass index; BSA, body surface area; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker; CCB, calcium channel blocker; SBP, systolic blood pressure; DBP, diastolic blood pressure; AP, augmentation pressure; AIx, augmentation index; RWT, relative wall thickness; LVM, left ventricular mass; LVMI, left ventricular mass index; IQR, interquartile range.